Qiagen reaches 2 NGS assay agreements

06:29 EDT 6 Jun 2017 | SmartBrief

Qiagen and Bristol-Myers Squibb have entered an agreement to look into the use of next-generation sequencing in the developme -More

Original Article: Qiagen reaches 2 NGS assay agreements


More From BioPortfolio on "Qiagen reaches 2 NGS assay agreements"

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

DNA sequencing
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...